SH NOR-SWITCH Related Content
Biosimilars: Improve access to treatment & reduce cost
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.